OOIR: Observatory of International Research

Papers

(The median citation count of Annals of Internal Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Attitudes Toward a Potential SARS-CoV-2 Vaccine	941
Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths	814
Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study	590
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors	530
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19	462
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization	422
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic	414
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	280
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers	270
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia	260
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2	257
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19	229
Depression	229
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building	194
Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic	187
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate	187
Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China	169
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection	167
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings	164
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs	155
Patient Trajectories Among Persons Hospitalized for COVID-19	153
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020	147
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness	139
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?	135
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults	133

Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments	128
Firearm Purchasing During the COVID-19 Pandemic: Results From the 2021 National Firearms Survey	128
Racial Disparities in COVID-19 Testing and Outcomes	128
QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies	126
Myasthenia Gravis Associated With SARS-CoV-2 Infection	126
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles	122
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France	121
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants	120
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States	116
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline	116
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update	113
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings	111
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis	110
Insomnia	110
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine	109
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities	109
Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults	108
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System	107
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting	107
A SARS-CoV-2 Cluster in an Acute Care Hospital	106
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting	101
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020	100
Worsening Spread of Candida auris in the United States, 2019 to 2021	99
A Novel International Monkeypox Outbreak	98
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021	97
Type 1 Diabetes Mellitus	95
Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series	95
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity	93
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt	93
Pulmonary Hypertension	93
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans	92
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries	90
Characteristics, Outcomes, and Trends of Patients With COVID-19–Related Critical Illness at a Learning Health System in the United States	90
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose	89
Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine	87
Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19	87
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19	85
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population	85
Insights From Rapid Deployment of a “Virtual Hospital” as Standard Care During the COVID-19 Pandemic	84
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus	83
Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients	82
Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons?	79
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials	79
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV	79
Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities	78
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors	77
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism	76
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial	75
Every Body Counts: Measuring Mortality From the COVID-19 Pandemic	75
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System	75

Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model	74
Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality	72
Multiple Sclerosis	71
Vitamin D Deficiency Increases Mortality Risk in the UK Biobank	71
The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic	70
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19	70
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update	70
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction	69
Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians	69
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes	69
Nonpharmacologic and Pharmacologic Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of	68
Major Update: Remdesivir for Adults With COVID-19	68
Preterm Birth and Stillbirth During the COVID-19 Pandemic in Sweden: A Nationwide Cohort Study	68
Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply	68
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation	67
Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract	67
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis	66
Retail Alcohol and Tobacco Sales During COVID-19	66
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports	66
Obesity and COVID-19 in New York City: A Retrospective Cohort Study	66
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection	65
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline	65
Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physi	65
Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiova	64
College Campuses and COVID-19 Mitigation: Clinical and Economic Value	64
Acute Pancreatitis	64
Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension	63
Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis	62
Addressing Postpandemic Clinician Mental Health	62
Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians	62
Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases	61
Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder	61
Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries	61
Masks and Face Coverings for the Lay Public	60
Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome	60
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn	60
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak	59
Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort	59
Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States	58
Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19	58
Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians	57
Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease	57
Remdesivir for Adults With COVID-19	57
Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality	55
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma	54
COVID-19 Vaccine: Promoting Vaccine Acceptance	54
Risk Compensation and COVID-19 Vaccines	54
Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment	53
Salivary Detection of COVID-19	53
Effect of Timing of and Adherence to Social Distancing Measures on COVID-19 Burden in the United States	52
Cannabis-Based Products for Chronic Pain	52
Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Works	52
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery	52
Patient Characteristics and Costs Associated With COVID-19–Related Medical Care Among Medicare Fee-for-Service Beneficiaries	51
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19	51
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care System	51
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants	51
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension	51
Characteristics of COVID-19 in Homeless Shelters	51
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease	51
Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China	50
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults	50
Hearing Loss	50
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels	50
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine	50
Low Back Pain	49
SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis	49
Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models	49
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020	48
Monkeypox: Avoiding the Mistakes of Past Infectious Disease Epidemics	48
Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs	48
Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population	48
A Framework for the Development of Living Practice Guidelines in Health Care	47
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19	47
Stepped Exercise Program for Patients With Knee Osteoarthritis	47
Sickle Cell Disease	47
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine	47
Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling	46
Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas	46
Prevalence of Asymptomatic SARS-CoV-2 Infection	45

The Challenge of Genetic Variants of Uncertain Clinical Significance	45
Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series	45
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers	45
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction	45
Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring	45
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series	45
Effects of Tai Chi or Conventional Exercise on Central Obesity in Middle-Aged and Older Adults	45
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine	45
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission	44
Medical Schools as Racialized Organizations: A Primer	44
Deep Venous Thrombosis	44
Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study	44
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge	44
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infect	43
Midodrine for the Prevention of Vasovagal Syncope	43
Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events	43
Clinician Perspectives on Caring for Dying Patients During the Pandemic	43
Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline	42
Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020	42
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population	42
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States	42
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France	42
Initiatives to Reduce Maternal Mortality and Severe Maternal Morbidity in the United States	41
Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes	41
Managing COVID-19 in a Novel, Rapidly Deployable Community Isolation Quarantine Facility	41
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation	41
First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists	41
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease	41
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure	41
COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System	40
Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation	40
A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation	40
Real-Time Computer-Aided Detection of Colorectal Neoplasia During Colonoscopy	40
Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank	39
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19	39
Treatment Patterns and Clinical Outcomes After the Introduction of the Medicare Sepsis Performance Measure (SEP-1)	39
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline	39
Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions	39
Predictors of Prolonged Opioid Use After Initial Prescription for Acute Musculoskeletal Injuries in Adults	39
Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020	39
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort	39
Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States	38
Total Ankle Replacement Versus Arthrodesis for End-Stage Ankle Osteoarthritis	38
Addressing Mistrust About COVID-19 Vaccines Among Patients of Color	38
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19	38
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups	38
Ethical Framework for Assessing Manual and Digital Contact Tracing for COVID-19	36
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation	36
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population	36
Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C–Viremic Donors to Hepatitis C–Negative Recipients: An Open-Label Nonrandomized Study	36
Clinical Practice Guidelines Registry: Toward Reducing Duplication, Improving Collaboration, and Increasing Transparency	35
Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points	35
Race and the False Precision of Glomerular Filtration Rate Estimates	34
The Problem of Aducanumab for the Treatment of Alzheimer Disease	34
Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians	34
Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data	34
The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis	34
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics	34
Feasibility of Separate Rooms for Home Isolation and Quarantine for COVID-19 in the United States	33
Monkeypox Virus–Associated Severe Proctitis Treated With Oral Tecovirimat: A Report of Two Cases	33
15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality	33
The Role of Medical Students During the COVID-19 Pandemic	33
Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports	33
Dyslipidemia	33
Menopause	32
MuSK Antibody–Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report	32
Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel	32
Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series	31
The Evidence Behind Robot-Assisted Abdominopelvic Surgery	31
Recurrence of Colorectal Neoplastic Polyps After Incomplete Resection	31
Large Language Models in Medicine: The Potentials and Pitfalls	31
Changes in Health Care Spending, Use, and Clinical Outcomes After Nonfatal Firearm Injuries Among Survivors and Family Members	31
Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era	30
Bereavement Care in the Wake of COVID-19: Offering Condolences and Referrals	30
Trends in Outpatient Care for Medicare Beneficiaries and Implications for Primary Care, 2000 to 2019	30
Pain, Analgesic Use, and Patient Satisfaction With Spinal Versus General Anesthesia for Hip Fracture Surgery	30
Affirmative Action Bans and Enrollment of Students From Underrepresented Racial and Ethnic Groups in U.S. Public Medical Schools	30
Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians	30
Associations of Serum Testosterone and Sex Hormone–Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men	30
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study	29
Community-Acquired Pneumonia	29
Cold Versus Hot Snare Polypectomy for Small Colorectal Polyps	29
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations	29
Alcohol Sales and Alcohol-Related Emergencies During the COVID-19 Pandemic	29
Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test–Based Screening	29
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19	29
The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline	29
A Comprehensive Policy Framework to Understand and Address Disparities and Discrimination in Health and Health Care: A Policy Paper From the American College of Physicians	29
Comparison of a Hemostatic Powder and Standard Treatment in the Control of Active Bleeding From Upper Nonvariceal Lesions	29
Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2	29
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial	29
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin	28
Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults	28
Increases in Actual Health Care Costs and Claims After Firearm Injury	28
Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure	28